US Pharma MarketingNovartis Q2 profits recover as revenue mantle passes to newer medicines
Novartis Q2 profits recover as revenue mantle passes to newer medicines is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Novartis continues to navigate a decisive period as newer portfolio assets start to offset patent pressures.
Source: Pharmaceutical Technology